Showing results (1361-1370 of 3,156) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|August 17, 2019
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trialPascale Varlet, Gwénaël Le Teuff, Marie-Cécile Le Deley, et al.Neuro-Oncology|August 18, 2019
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT ConsortiumHirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, et al.Neuro-Oncology|August 2, 2019
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trialJulia Furtner, Els Genbrugge, Thierry Gorlia, et al.Neuro-Oncology|November 3, 2018
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannomaDaniel Lewis, Federico Roncaroli, Erjon Agushi, et al.Neuro-Oncology|October 23, 2018
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survivalFlóra John, Edit Bosnyák, Natasha L Robinette, et al.Neuro-Oncology|November 14, 2018
Introduction of novel agents in the treatment of primary CNS lymphomaChristian Grommes, Lakshmi Nayak, Han W Tun, et al.Neuro-Oncology|November 10, 2018
Survivorship care planning and implementation in neuro-oncologyHeather Leeper, Kathrin MilburyNeuro-Oncology|November 10, 2018
Updates in prognostic markers for gliomasElisa Aquilanti, Julie Miller, Sandro Santagata, et al.Neuro-Oncology|November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment toolPaul W Sperduto, Brian J Deegan, Jing Li, et al.Neuro-Oncology|September 21, 2019
Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomasMaya Harary, Vasileios K Kavouridis, Matthew Torre, et al.Pageof 316